What is Cirrus Therapeutics worth?
$26.0Mlast known valuation
Cirrus Therapeutics last raised $6.7M in its Early Stage VC (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Cirrus Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Early Stage VC | $6.7M | ▮ | ▮ |
How Cirrus Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cirrus Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Cirrus Therapeutics worth?
- Cirrus Therapeutics's last known valuation is $26.0M.
- How much has Cirrus Therapeutics raised?
- Cirrus Therapeutics has raised $11.0M in total funding across 1 recorded rounds.
- When did Cirrus Therapeutics last raise?
- Cirrus Therapeutics last raised in Aug 2025 (Early Stage VC), raising $6.7M.